Skip to content
value.today

Aardvark Therapeutics, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2017
Total raised
$103 M
3 rounds on record
Latest round
$85 M
May 2024
First round on record
May 2019
Today
Went public
See the company page

Aardvark Therapeutics, Inc. is listed today as Aardvark Therapeutics, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Aardvark Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$85 MNo. 3$50 to $250 million

Aardvark Therapeutics, Inc.: Raise no. 3, May 2024

Investors in this round

31 investors had bought by the notice of May 15, 2024: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$85 M of $85 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,699,999
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nelson Sun · Executive Officer
  • Tien-Li Lee · Executive Officer, Director
  • Jeffrey Chi · Director
  • Victor Tong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cantor Fitzgerald & Co. (CRD 134) · New York, New YorkSold in CA, CO, CT, FL, MA, NY, TX

Signed by Tien-Li Lee, Ceo. Newest notice filed May 15, 2024. Read the notice at the SEC.

equitySEC
May 2021$9 MNo. 2$2 to $10 million

Aardvark Therapeutics, Inc.: Raise no. 2, May 2021

Investors in this round

8 investors had bought by the notice of Jun 7, 2021: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $30 M offered; $21 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tien-Li Lee · Executive Officer, Director
  • Bob Shin · Director
  • Henry Ji · Director
  • Jeffrey Chi · Director
  • Jerel Banks · Director
  • Zachary Hornby · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tien-Li Lee, Ceo. Newest notice filed Jun 7, 2021. Read the notice at the SEC.

equitySEC
May 2019$9 MNo. 1$2 to $10 million

Aardvark Therapeutics, Inc.: Raise no. 1, May 2019

Investors in this round

12 investors had bought by the notice of May 24, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $15 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tien-Li Lee · Executive Officer, Director
  • Bob Shin · Director
  • Jeffrey Chi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tien-Li Lee, Chief Executive Officer. Newest notice filed May 24, 2019. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Aardvark Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2024

Products and services#

No products or services of Aardvark Therapeutics, Inc. are on record.

Investors#

No investor of Aardvark Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Largest shareholders today

Institutions holding Aardvark Therapeutics, Inc. shares, as of Sep 30, 2026.

As of Sep 30, 2026

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Aardvark Therapeutics, Inc.
NameRoleNamed in
Nelson SunExecutive officerMay 2024
Tien-Li LeeExecutive officerMay 2024
Jeffrey ChiDirectorMay 2024
Tien-Li LeeDirectorMay 2024
Victor TongDirectorMay 2024
Bob ShinDirectorJun 2021
Henry JiDirectorJun 2021
Jerel BanksDirectorJun 2021
Zachary HornbyDirectorJun 2021

Went public since 2025. Its SEC number is that of a company listed on a stock exchange.